Is Aldeyra Therapeutics on the Brink of a Breakthrough with Reproxalap

Related Articles

Is the U.S. on the Brink of a NATO Exit

6 months ago

Is Edgewise Therapeutics (EWTX) on the Cusp of a Breakthrough Year

7 months ago

Is Europe on the Brink of Stagflation

6 months ago

Is Global Finance on the Brink of a Digital Overhaul

5 months ago

Category

You may also like

Stock News•3 weeks ago

Aldeyra to Appeal FDA Rejection of Reproxalap for Dry Eye Disease

Aldeyra Therapeutics will file a formal dispute resolution request with the FDA's Office of New Drugs to challenge the agency's latest complete response letter rejecting reproxalap for dry eye disease...

ALDX

Share

Stock News•2 months ago

Ocular Therapeutix, Inc. (OCUL) Discusses Regulatory Progress and NDA Filing Plans for AXPAXLI Transcript

Ocular Therapeutix discussed regulatory progress and NDA filing plans for AXPAXLI, a key pipeline candidate. The update could signal near-term filing timing, though no specific dates or financial figu...

OCUL

Share

Stock News•2 months ago

Some Potential Merit Within MeiraGTx Holdings

MeiraGTx Holdings could see significant upside from late-stage gene therapy assets. AAV2-hAQP1 targets a $3.7B peak market for xerostomia, with pivotal Phase 2 data expected in 2Q27.

MGTX

Share